CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Shares of CVS Health Corp. CVS inched 0.44% higher to $54.27 Wednesday, on what proved to be an all-around favorable trading ...

CVS Health will report third-quarter earnings before the market opens Wednesday as the pharmacy and health-care provider ...

Here are two brilliant options along those lines: CVS Health ( CVS 0.44%) and Bristol Myers Squibb ( BMY -1.03%). Find out ...

CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

In addition to the top- and bottom-line results, CVS Health cut its full-year profit outlook for a third consecutive quarter, ...

Eva Marie Uzcategui / Bloomberg / Getty Images CVS Health reported better-than-expected quarterly results, and the new CEO ...

CVS HEALTH CORP (CVS) is a large-cap growth stock in the Retail (Drugs) industry. The rating using this strategy is 70% based on the firm’s underlying fundamentals and the stock’s valuation.